Loading...
XSESNPL
Market cap14mUSD
Dec 20, Last price  
0.15SGD
1D
15.38%
IPO
-26.83%
Name

Niks Professional Ltd

Chart & Performance

D1W1MN
XSES:NPL chart
P/E
11.57
P/S
1.80
EPS
0.01
Div Yield, %
48.72%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
11m
-2.17%
11,192,00011,699,00011,095,00010,854,000
Net income
2m
-38.98%
2,999,0003,339,0002,763,0001,686,000
CFO
2m
-35.25%
4,974,0004,411,0003,387,0002,193,000
Dividend
May 16, 20240.01 SGD/sh

Profile

Niks Professional Ltd is an integrated medical skin care provider, incorporating family dermatology and aesthetic medical services, skin care products, facial treatment and medical camouflage service under one roof and a single NIKS brand. It owns and operates three medical clinics in Singapore focusing on family dermatology and aesthetic medicine. its clinical services are complemented by a portfolio of some 200 quality medical skin care products. its products are conceptualized and developed in Singapore and made in the finest factories in the United States and Europe.
IPO date
Oct 27, 2023
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFY
2023‑122022‑122021‑122020‑12
Income
Revenues
10,854
-2.17%
11,095
-5.16%
11,699
4.53%
Cost of revenue
8,150
7,602
7,408
Unusual Expense (Income)
NOPBT
2,704
3,493
4,291
NOPBT Margin
24.91%
31.48%
36.68%
Operating Taxes
488
406
697
Tax Rate
18.05%
11.62%
16.24%
NOPAT
2,216
3,087
3,594
Net income
1,686
-38.98%
2,763
-17.25%
3,339
11.34%
Dividends
(9,500)
(3,660)
(7,920)
Dividend yield
46.84%
Proceeds from repurchase of equity
4,578
560
BB yield
-22.57%
Debt
Debt current
522
338
260
Long-term debt
2,346
2,038
2,292
Deferred revenue
Other long-term liabilities
Net debt
(6,218)
(9,995)
(10,711)
Cash flow
Cash from operating activities
2,193
3,387
4,411
CAPEX
(300)
(63)
(311)
Cash from investing activities
(169)
(47)
(311)
Cash from financing activities
(5,308)
(4,202)
(7,911)
FCF
869
3,475
2,604
Balance
Cash
9,086
12,371
13,263
Long term investments
Excess cash
8,543
11,816
12,678
Stockholders' equity
19,382
22,326
23,423
Invested Capital
12,273
11,355
11,632
ROIC
18.76%
26.86%
32.62%
ROCE
12.99%
15.07%
17.60%
EV
Common stock shares outstanding
130,000
130,000
130,000
Price
0.16
 
Market cap
20,280
 
EV
14,062
EBITDA
3,444
4,284
5,173
EV/EBITDA
4.08
Interest
76
77
64
Interest/NOPBT
2.81%
2.20%
1.49%